Madrigal Pharma (MDGL) option implied volatility into FDA approval

Madrigal Pharma (NASDAQ: MDGL) 30-day option implied volatility is at 151; compared to its 52-week range of 49 to 176 into FDA approves Madrigal Pharmaceuticals' Rezdiffra.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
• Tractor Supply (TSCO) call put ratio calls to 3.8 calls to 1 put with a focus on 6300 contracts of September 36 calls
• GFL Environmental (GFL) spreader of 17500 contracts of December 45 and 50 calls